Twist Bioscience Corporation (TWST) एक सार्वजनिक रूप से कारोबार करने वाली कंपनी है में स्वास्थ्य सेवा क्षेत्र, संचालन करती है Medical - Diagnostics & Research उद्योग. कंपनी का मुख्यालय है South San Francisco, CA, United States. वर्तमान CEO हैं Emily Marine Leproust.
TWST के पास है IPO तिथि 2018-10-31, 923 पूर्णकालिक कर्मचारी, पर सूचीबद्ध NASDAQ Global Select, बाजार पूंजीकरण $3.52B.
Twist Bioscience Corporation is a synthetic biology company that manufactures and sells synthetic DNA-based products using its proprietary DNA synthesis platform, which writes DNA directly onto silicon chips. The company offers a diverse portfolio including synthetic genes, sample preparation tools, antibody libraries for drug discovery, and DNA-based digital data storage solutions. Twist has established strategic collaborations with leading pharmaceutical and biotechnology firms such as Boehringer Ingelheim, Kyowa Kirin, and Centogene to advance sequencing tools and therapeutic antibody discovery. Founded in 2013 and headquartered in South San Francisco, California, the company serves the pharmaceutical, diagnostics, and data storage industries.
